BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8706255)

  • 1. Formation of DNA adducts by the co-mutagen norharman with aromatic amines.
    Mori M; Totsuka Y; Fukutome K; Yoshida T; Sugimura T; Wakabayashi K
    Carcinogenesis; 1996 Jul; 17(7):1499-503. PubMed ID: 8706255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers.
    Hada N; Totsuka Y; Enya T; Tsurumaki K; Nakazawa M; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
    Mutat Res; 2001 Jun; 493(1-2):115-26. PubMed ID: 11516721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline.
    Totsuka Y; Hada N; Matsumoto K; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
    Carcinogenesis; 1998 Nov; 19(11):1995-2000. PubMed ID: 9855015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human exposure to mutagenic/carcinogenic heterocyclic amines and comutagenic beta-carbolines.
    Wakabayashi K; Totsuka Y; Fukutome K; Oguri A; Ushiyama H; Sugimura T
    Mutat Res; 1997 May; 376(1-2):253-9. PubMed ID: 9202762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorination of harman and norharman with sodium hypochlorite and co-mutagenicity of the chlorinated products.
    Nakano K; Suyama K; Fukazawa H; Uchida M; Wakabayashi K; Shiozawa T; Terao Y
    Mutat Res; 2000 Oct; 470(2):141-6. PubMed ID: 11027968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagens formed from beta-carbolines with aromatic amines.
    Totsuka Y; Takamura-Enya T; Nishigaki R; Sugimura T; Wakabayashi K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 802(1):135-41. PubMed ID: 15036005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of norharman on the mutagenicity of toluidine metabolites.
    Gupta RL; Kaur IP; Gupta AK; Pathak DP; Juneja TR
    Toxicol Lett; 1989 Jul; 48(1):75-81. PubMed ID: 2665189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic aspects of the comutagenic action of norharman.
    Sugimura T; Nagao M; Wakabayashi K
    Adv Exp Med Biol; 1981; 136 Pt B():1011-25. PubMed ID: 7046384
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure of DNA adduct formed with aminophenylnorharman, being responsible for the comutagenic action of norharman with aniline.
    Totsuka Y; Takamura-Enya T; Kawahara N; Nishigaki R; Sugimura T; Wakabayashi K
    Chem Res Toxicol; 2002 Oct; 15(10):1288-94. PubMed ID: 12387627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of sister chromatid exchanges and chromosome aberrations in cultured mammalian cells treated with aminophenylnorharman formed by norharman with aniline.
    Ohe T; Takata T; Maeda Y; Totsuka Y; Hada N; Matsuoka A; Tanaka N; Wakabayashi K
    Mutat Res; 2002 Mar; 515(1-2):181-8. PubMed ID: 11909766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo formation of aminophenylnorharman from norharman and aniline.
    Totsuka Y; Kataoka H; Takamura-Enya T; Sugimura T; Wakabayashi K
    Mutat Res; 2002 Sep; 506-507():49-54. PubMed ID: 12351144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-mutagenic effect of norharman with N-nitrosamine derivatives.
    Wakabayashi K; Nagao M; Kawachi T; Sugimura T
    Mutat Res; 1981 Jan; 80(1):1-7. PubMed ID: 7010130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse.
    Masumura K; Totsuka Y; Wakabayashi K; Nohmi T
    Carcinogenesis; 2003 Dec; 24(12):1985-93. PubMed ID: 12970073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of S9 mix from rat oesophagus, salivary gland, and liver on the mutagenicity of the rat oesophageal carcinogen N-nitroso-N-methylaniline in the Salmonella typhimurium assay.
    Anderson D; Blowers SD; Craddock VM
    Mutat Res; 1985; 142(1-2):13-8. PubMed ID: 3883137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of appearance of mutagenicity of N-nitrosodiphenylamine with norharman.
    Wakabayashi K; Nagao M; Kawachi T; Sugimura T
    IARC Sci Publ; 1982; (41):695-707. PubMed ID: 7141576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comutagenic effect of norharman with aminopyridine derivatives.
    Wakabayashi K; Yahagi T; Nagao M; Sugimura T
    Mutat Res; 1982 Oct; 105(4):205-10. PubMed ID: 7133029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dependence on Salmonella typhimurium enzymes of mutagenicities of nitrobenzene and its derivatives in the presence of rat-liver S9 and norharman.
    Suzuki J; Takahashi N; Kobayashi Y; Miyamae R; Ohsawa M; Suzuki S
    Mutat Res; 1987 Jun; 178(2):187-93. PubMed ID: 3295532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of norharman on the mutagenicity of chlorophenylhydroxylamine and its metabolism with rat liver S9.
    Suzuki J; Kobayashi Y; Monden S; Suzuki S
    Mutat Res; 1986 Sep; 162(2):165-72. PubMed ID: 3528827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological significance of aminophenyl-β-carboline derivatives formed from co-mutagenic action of β-carbolines and aniline and o-toluidine and its effect on tumorigenesis in humans: A review.
    Totsuka Y; Wakabayashi K
    Mutat Res Genet Toxicol Environ Mutagen; 2020; 850-851():503148. PubMed ID: 32247557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicities of mono-nitrobenzene derivatives in the presence of norharman.
    Suzuki J; Koyama T; Suzuki S
    Mutat Res; 1983 May; 120(2-3):105-10. PubMed ID: 6341826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.